Cytiva triples its single-use consumables capacity in China
Cytiva officials say the company continues to expand its manufacturing capacity for single-use bioprocessing consumables in China. Together with Wego Pharmaceutical in the country, the two companies are expanding an existing facility jointly launched in 2018. These newly added manufacturing lines will triple the single-use consumable supply capacity in the Asia-Pacific region, according to Cytiva.
The planned expansion will consist of eight additional new manufacturing lines, two of which are expected to be launched by the end of 2021, with the remaining six lines scheduled for the third quarter of 2022. It adds 1,300 m2 to the ISO Class 7 cleanroom manufacturing area and also includes a2 warehouse designed to save more time and increase flexibility for customers.
These expansions are part of the recently announced $ 1.5 billion investment by Cytiva and Pall.
In addition to the increased capacity, Cytiva is also bringing new products, 100L to 1000L Xcellerex mixing bags, to the expanded facility’s manufacturing portfolio. The new products will incorporate Fortem technology (Cytiva’s single-use characterized film).
“With increasing global demand, customers need more flexibility and adaptability, resulting in a growing trend of intraregional manufacturing for the region,” said Francis Van Parys, vice president, Asia Pacific , Cytiva. “Our collaboration with Wego has proven to be successful for our customers in China, and this increased capacity will help the region improve manufacturing resilience with cost savings and reduced delivery times, while providing an equivalent product and high quality to our customers in the wider region. “
According to BioPlan Associates’ annual biofabrication report, adoption of single-use technology is expected to increase rapidly in clinical production and manufacturing. Over 85% of current pre-commercial and clinical manufacturing lines / facilities are single-use.